ASPEN PHARMACR Revenue, Profits - APNHY Annual Income Statement

Add to My Stocks
$21.77 $0.23 (1.07%) APNHY stock closing price Mar 21, 2018 (Closing)

Financial analysis of ASPEN PHARMACR involves more than just checking the ASPEN PHARMACR stock price, by looking at the financial statements of the company in detail. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the APNHY stock is bound to reflect the impact of the YOY growth of 22.57%. Along with ASPEN PHARMACR assets and ASPEN PHARMACR free cash flow, ASPEN PHARMACR profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $374.85M and the 2017 revenue is $3.03B.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jul - Jun20172016
ASPEN PHARMACR Revenues or Net Sales
Cost Of Goods Sold (COGS)1.57B1.23B
Research & Development Expense--
Selling General & Admin Expense852.6M617.66M
Income Before Depreciation Depletion Amortization610.04M624.59M
Depreciation Depletion Amortization--
Non Operating Income22.05M20.82M
Interest Expense176.4M222.08M
Provision for Income Taxes80.85M124.92M
Investment Gains Losses--
Other Income--
Income Before Extraordinaries & Disc Operations374.85M298.42M
Extraordinary Items & Discontinued Operations--
ASPEN PHARMACR Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS--
Average Shares used to compute Basic EPS--
Income Before Nonrecurring Items--
Income from Nonrecurring Items--
ASPEN PHARMACR Earnings Per Share Basic Net
ASPEN PHARMACR Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items--
Preferred Dividends Acc Pd--
Dividends Common--
Dividend Per Share Common0.130.14
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on ASPEN PHARMACR stock analysis. It helps to look at the following income statement items:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: ASPEN PHARMACR revenue chart implies that the company is growing. It has been the case with ASPEN PHARMACR. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $374.85M for APNHY stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The APNHY financials along with ASPEN PHARMACR historical stock prices provide a lot of details about the firm.

ASPEN PHARMACR Income Statement - Key Financial Ratios